European Journal of Endocrinology

Article	Citations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	425
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19	269
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors	139
GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020	122
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARA	97
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma	71
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study	67
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome	66
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline	56
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!	55
DIAGNOSIS OF ENDOCRINE DISEASE: Diagnosing and classifying diabetes in diseases of the exocrine pancreas	54
DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease	53
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy	51
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement	50
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection	49
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study	49
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients	46
Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study	43
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia	42
Multiple testing: when is many too much?	41
Global epidemiology of acromegaly: a systematic review and meta-analysis	41
The interplay of thyroid hormones and the immune system – where we stand and why we need to know about it	41
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline	40
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY	40
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors	39

Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?	38
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome	37
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls	37
Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism	36
Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus	35
MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene	35
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations	34
Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules	34
MECHANISMS IN ENDOCRINOLOGY: Local and systemic effects of glucocorticoids on metabolism: new lessons from animal models	33
DNAJC3 deficiency induces β-cell mitochondrial apoptosis and causes syndromic young-onset diabetes	33
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people	33
MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach	33
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary amenorrhea and female delayed puberty	32
Circulating fatty acids and risk of gestational diabetes mellitus: prospective analyses in China	32
MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity	32
Effects of iodine supplementation during pregnancy on pregnant women and their offspring: a systematic review and meta-analysis of trials over the past 3 decades	31
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19	31
When observational studies can give wrong answers: the potential of immortal time bias	30
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response	29
ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases	29
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments	28
LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells	28
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis	27
GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas	27
MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?	27
Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy	27
Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study	27
Preferences of patients and clinicians for treatment of Graves’ disease: a discrete choice experiment	26
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses	26
Abnormal body composition in patients with adrenal adenomas	25
Methimazole-induced remission rates in pediatric Graves’ disease: a systematic review	25
Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review	25
Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study	25
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study	25
Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients	25
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard	25
Effects of endogenous GIP in patients with type 2 diabetes	25
Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study	25
A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen	24
International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry	24
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma	24
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia	24
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review	24
MANAGEMENT OF ENDOCRINE DISEASE: Glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?	23
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors	23
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension	23
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden	22
AMH as part of the diagnostic PCOS workup in large epidemiological studies	22
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis	21
SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years	21

ENDOCRINOLOGY IN PREGNANCY: Metabolic impact of bile acids in gestation	21
Using electronic health record data for clinical research: a quick guide	21
The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review	21
Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study	21
Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study	21
Transcription factor immunohistochemistry in the diagnosis of pituitary tumours	21
Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation	20
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?	20
Exposure to non-persistent pesticides and puberty timing: a systematic review of the epidemiological evidence	20
Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis	20
Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register	20
MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions	20
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism	20
Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study	19
Active management of severe hyponatraemia is associated with improved mortality	19
Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis	19
Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV	19
Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis	19
Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study	19
MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation	19
The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes	19
MANAGEMENT OF ENDOCRINE DISEASE: Papillary thyroid microcarcinoma: toward an active surveillance strategy	19
The phenotypic spectrum associated with OTX2 mutations in humans	18
Sex-specific associations of circulating testosterone levels with all-cause and cause-specific mortality	18
Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study	18
Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma	18
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior	18
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity	18
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study	18
Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease	18
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension	18
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?	17
MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases	17
Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing’s syndrome	17
The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease	17
Semen quality and testicular adrenal rest tumour development in 46,XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement	17
Effects of 8 years of growth hormone treatment on scoliosis in children with Prader–Willi syndrome	17
11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease	16
ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus	16
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease	16
Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening	16
Metabolic disease and adverse events from immune checkpoint inhibitors	16
Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study	16
The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series	16
Real-life clinical impact of a five-tiered classification of pituitary tumors	16
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and management	16
Patients with low IGF-I after curative surgery for Cushing’s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy	16
Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study	15
Clinical course and imaging characteristics of benign adrenal cysts: a single-center study of 92 patients	15
ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma	15
MECHANISMS IN ENDOCRINOLOGY: The gut–brain axis: regulating energy balance independent of food intake	15
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience	15
MECHANISMS IN ENDOCRINOLOGY: Paracrine and endocrine control of the growth hormone axis by estrogen	15
Genetic evaluation supports differential diagnosis in adolescent patients with delayed puberty	15
Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease	15
Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy	15
MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications	15
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study	15
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report	15
Long-term morbidity and mortality in patients diagnosed with an insulinoma	15
Steroid reference intervals in women: influence of menopause, age and metabolism	15
Thyroid hormone resistance index and mortality in euthyroid subjects: [email protected] study	15
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study	14
Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia	14
Rapid control of severe ectopic Cushing’s syndrome by oral osilodrostat monotherapy	14
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders	14
GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review	14
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis	14
Is human obesity an inflammatory disease of the hypothalamus?	14
Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidence	14
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia	14
Characterization of patients with adrenal insufficiency and frequent adrenal crises	14
Efficacy and tolerance of osilodrostat in patients with Cushing’s syndrome due to adrenocortical carcinomas	14
Increased liver fat associates with severe metabolic perturbations in low birth weight men	14
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies	14
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib	13
THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage	13
Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study	13
Effect of obstructive sleep apnea on glucose metabolism	13
Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients	13

Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas	13
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies	13
Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage	13
MANAGEMENT OF ENDOCRINE DISEASE: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose	13
Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study	13
Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care	13
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial	13
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma	13
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer	13
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS	13
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome	13
Evaluation of an individualized education program in pituitary diseases: a pilot study	13
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients	13
The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients	13
Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification	13
Target therapy forBRAFmutated anaplastic thyroid cancer: a clinical and molecular study	13
Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank	12
ESE audit on management of adult growth hormone deficiency in clinical practice	12
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls	12
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool	12
Long-term follow-up of cystic thyroid nodules treated with percutaneous ethanol injection (PEI) using two different approaches	12
Circadian rhythms of 11-oxygenated C19 steroids and ∆5-steroid sulfates in healthy men	12
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes	12
Pubertal development and premature ovarian insufficiency in patients with APECED	12
Clinical utility of sonographic features in indeterminate pediatric thyroid nodules	12
Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study	12
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study	12
Randomised trial of block and replace vs dose titration thionamide in young people with thyrotoxicosis	12
Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes	12
Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study	12
MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency – mechanistic insights from Laron syndrome and tailored animal models	11
PM20D1 is a circulating biomarker closely associated with obesity, insulin resistance and metabolic syndrome	11
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature	11
Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus	11
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study	11
Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk	11
Filamin A and parafibromin expression in parathyroid carcinoma	11
Introduction to diagnostic test accuracy studies	11
DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer	11
Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark	11
Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population	11
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome	11
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism	11
Carpal tunnel syndrome in acromegaly: a nationwide study	11
Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load	11
Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting	11
EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management	11
Effect of hyponatremia normalization on osteoblast function in patients with SIAD	11
Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules	11
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma	11
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS	11
Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer	11